2026 Tampa Patient and Family Conference
Patients with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood c
Acute Myeloid Leukemia (AML)
Aplastic Anemia, MDS, PNH Virtual Support Group-Saturdays-2026 May
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious co
Inhibiting ferroptosis enhances ex vivo expansion of human haematopoietic stem cells
Original Publication Date
Article Source
External Web Content
Abstract Improved ex vivo expansion of human haematopoietic stem cells (HSCs) would considerably advance transplantation and genome-engineered therapies, yet existing culture methods still allow substantial HSC loss. Here we show that this attrition is driven largely by…
Mutant p53 promotes clonal hematopoiesis through generating a chronic inflammatory microenvironment
Original Publication Date
Article Source
External Web Content
Aged individuals with somatic TP53 mutations manifest clonal hematopoiesis (CH) and are at high risk of developing myeloid neoplasms. However, the underlying mechanisms are not fully understood. Here we show that inflammatory stress confers a competitive advantage to p53 mutant…
Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s)
Original Publication Date
Article Source
External Web Content
Abstract NRAS and KRAS mutations, commonly identified alongside ancestral co-mutations, are generally regarded as pathogenic in adults presenting with monocytosis and/or cytopenia(s). However, their significance in isolation is not well defined. We studied a multi-institutional…
Studies Point to a Growing Role for New Therapies and Immunotherapies in Treating Blood Cancers
Original Publication Date
Article Source
External Web Content
Chemotherapy-free approaches could offer comparable efficacy with less toxicity (ORLANDO, Dec. 7, 2025) — Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as a mainstay of treatment for…
Health Equity for Non Transplant Treatment Panel Discussion
Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Eileen Hu, MD, PhD
Yazan F. Madanat, MD
Addresses the barriers of ageism, geographic and cultural challenges, delays in diagnosis, limited English proficiency, financial toxicity, and long-term supportive care in pathophysiology, diagnosis, and clinical management of bone marrow failure diseases. For more content like…
Health Equity for Aplastic Anemia, MDS, and AML Transplantation Panel Discussion
Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Julio Alvarenga Thiebaud, MD.
Clayton Jackson, MD
Addresses the barriers of ageism, geographic and cultural challenges, delays in diagnosis, limited English proficiency, financial toxicity, and long-term supportive care in pathophysiology, diagnosis, and clinical management of bone marrow failure diseases. For more content like…
Tara Lin, MD, PhD
Institution
University of Kansas Medical Center
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
About
Dr. Lin received her undergraduate degree from the University of Virginia and her MD from the Medical College of Virginia/Virginia Commonwealth University. She earned a Master of Science degree in Clinical Research from Tulane University. She completed Internal Medicine residency at the University of Maryland and Medical Oncology Fellowship at Johns Hopkins. She then completed a post-doctoral fellowship at UCLA in the laboratory of Dr. Kathleen Sakamoto with a focus on leukemia stem cells. She served on the faculty in Hematology/Oncology at the Louisiana State University Health Sciences Center